StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI)
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Down 1.3 % Shares of CASI stock opened at $2.21 on Tuesday. CASI Pharmaceuticals has a 12 month low of $2.04 […]
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Down 1.3 % Shares of CASI stock opened at $2.21 on Tuesday. CASI Pharmaceuticals has a 12 month low of $2.04 […]
